EUVIMEDEUVIMED entdecken
Crossref

Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis

Xuexuan Ding, Fangfang Yan, Wenjian Wang, Jingtong Qin, Lianxiang Luo

International Immunopharmacology · 2024-04 · 131 · 111865

DOI: 10.1016/j.intimp.2024.111865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-04. Verfasst von Xuexuan Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Guangdong Medical University, Zhanjiang 524023, Guangdong, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of ulcerative colitis (UC) continues to rise globally, but effective therapeutic targets are still lacking. In recent years, numerous studies have indicated that lipid therapies could offer a novel perspective for UC treatment. Given the absence of prior research utilizing high-throughput data to identify target genes associated with lipid metabolism, we conducted this work. METHODS: The training set for this study was derived from four datasets within the Gene Expression Omnibus (GEO), encompassing a total of 357 UC patients. We employed four machine learning methods (LASSO, SVM, RF, and Boruta) to jointly identify core biomarkers in these patients, whose aberrant expression needed to be validated in independent datasets and in dextrose sulfate sodium salt (DSS)-induced UC mouse models. Regarding metabolomics, we detected abnormal oxidized lipids in the serum of UC mouse using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in conjunction with orthogonal partial least squares-discriminant analysis (OPLS-DA). RESULTS: Phospholipase A2 Group IIA (PLA2G2A) was first identified as a possible biomarker for UC, with AUC values of 0.810 and 1.000 in the two validation sets, while in animal models the gene showed similarly significant up-regulation in damaged intestinal mucosa. Further analysis of this gene showed that it was positively correlated with 17 immune cell types and histological severity. Additionally, we pioneered the development of a lipid metabolism score in UC research, which outperformed all individual genes in terms of disease diagnostic efficacy (AUC values of 0.980 and 1.000 for the two validation sets, respectively). Finally, the metabolomics study also identified 31 significantly abnormal oxidized lipids, including 12-HHT and DHA. CONCLUSIONS: PLA2G2A is a key therapeutic target for UC, and oxidized lipids such as 12-HHT can serve as potential serologic indicators for diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansMiceAnimalsChromatography, LiquidLipid MetabolismTandem Mass SpectrometryMetabolomicsBiomarkersGene Expression ProfilingLipidsDisease Models, AnimalDextran Sulfate

Stichwörter der Autor:innen

Lipid metabolismMachine learningMetabolomicsOxidized lipidsPLA2G2AUlcerative colitis

Substanzen

BiomarkersLipidsDextran Sulfate

Autor:innen und Institutionen

  • The First Clinical College, Guangdong Medical University, Zhanjiang 524023, Guangdong, China.
  • The Marine Biomedical Research Institute of Guangdong Zhanjiang, School of Ocean and Tropical Medicine. Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
  • The Marine Biomedical Research Institute of Guangdong Zhanjiang, School of Ocean and Tropical Medicine. Guangdong Medical University, Zhanjiang, Guangdong, 524023, China. Electronic address: luolianxiang321@gdmu.edu.cn.

Förderung

  • Guangdong Medical University

Zitieren

APA

Ding, X., Yan, F., Wang, W., Qin, J., & Luo, L. (2024). Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis. International Immunopharmacology, 131, 111865. https://doi.org/10.1016/j.intimp.2024.111865

Vancouver

Ding X, Yan F, Wang W, Qin J, Luo L. Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis. International Immunopharmacology. 2024;131:111865. doi:10.1016/j.intimp.2024.111865

BibTeX
@article{Ding2024,
  author = {Ding, Xuexuan and Yan, Fangfang and Wang, Wenjian and Qin, Jingtong and Luo, Lianxiang},
  title = {Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {131},
  pages = {111865},
  doi = {10.1016/j.intimp.2024.111865}
}
Kostenlos starten →